5. If a patent waiver were implemented, would the companies that developed vaccines have a moral responsibility to share information about ingredients and production processes in order to speed up worldwide manufacturing and reduce the global impact of COVID-IQ? 6. What approach to handling intellectual property for COVID-19 vaccines would leave the world best prepared to deal with the next major pandemic